As an important pro-metastasis molecule, uPAR overexpression was found in patients with aggressive cancers, including ovarian cancer [22,23], while uPAR downregulation reduced tumor growth and metastatic potential [24]. This evidence concerns the gene PLAUR and ovarian carcinoma.